Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors

Pancreatic cancer is a lethal disease and notoriously difficult to treat. Only a small proportion is curative by surgical resection, whilst standard chemotherapy for patients with advanced disease has only a modest effect with substantial toxicity. Clearly there is a need for the continual developme...

Full description

Bibliographic Details
Main Author: Hidemi Rikiishi
Format: Article
Language:English
Published: MDPI AG 2010-11-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/2/4/2026/
id doaj-1cdcb8ceae0a4564837672c15383d922
record_format Article
spelling doaj-1cdcb8ceae0a4564837672c15383d9222020-11-24T23:57:21ZengMDPI AGCancers2072-66942010-11-01242026204310.3390/cancers2042026Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase InhibitorsHidemi RikiishiPancreatic cancer is a lethal disease and notoriously difficult to treat. Only a small proportion is curative by surgical resection, whilst standard chemotherapy for patients with advanced disease has only a modest effect with substantial toxicity. Clearly there is a need for the continual development of novel therapeutic agents to improve the current situation. Currently, there is a bulk of data indicating the important function of autophagy in cancer. While genetic evidence indicates that autophagy functions as a tumor suppressor, it is also apparent that autophagy can promote the survival of established tumors under stress conditions and in response to chemotherapy. This review provides a spectrum of potential pharmacological agents and autophagic approaches to enhance cell killing in pancreatic cancer. http://www.mdpi.com/2072-6694/2/4/2026/pancreatic cancerautophagyapoptosisepigeneticshistone deacetylaseER stress
collection DOAJ
language English
format Article
sources DOAJ
author Hidemi Rikiishi
spellingShingle Hidemi Rikiishi
Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
Cancers
pancreatic cancer
autophagy
apoptosis
epigenetics
histone deacetylase
ER stress
author_facet Hidemi Rikiishi
author_sort Hidemi Rikiishi
title Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
title_short Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
title_full Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
title_fullStr Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
title_full_unstemmed Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
title_sort possible role of autophagy in the treatment of pancreatic cancer with histone deacetylase inhibitors
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2010-11-01
description Pancreatic cancer is a lethal disease and notoriously difficult to treat. Only a small proportion is curative by surgical resection, whilst standard chemotherapy for patients with advanced disease has only a modest effect with substantial toxicity. Clearly there is a need for the continual development of novel therapeutic agents to improve the current situation. Currently, there is a bulk of data indicating the important function of autophagy in cancer. While genetic evidence indicates that autophagy functions as a tumor suppressor, it is also apparent that autophagy can promote the survival of established tumors under stress conditions and in response to chemotherapy. This review provides a spectrum of potential pharmacological agents and autophagic approaches to enhance cell killing in pancreatic cancer.
topic pancreatic cancer
autophagy
apoptosis
epigenetics
histone deacetylase
ER stress
url http://www.mdpi.com/2072-6694/2/4/2026/
work_keys_str_mv AT hidemirikiishi possibleroleofautophagyinthetreatmentofpancreaticcancerwithhistonedeacetylaseinhibitors
_version_ 1725454366356275200